RFID in Healthcare: The Cure for Counterfeit Drugs

Shahram Moradpour, Senior Director of Market Development

Sun Microsystems, United States

Downloads

Presentation^*

Audio^*

Counterfeit pharmaceuticals and biologics are a growing problem affecting patient safety
RFID minimizes the risk of counterfeited and diverted product by allowing companies to track each drug as it moves through the supply chain
RFID coupled with Electronic Product Code (EPC) and electronic pedigrees are key elements recommended by the FDA to combat counterfeit drugs
Companies can gain business value in expedited returns processing and more precise recalls in addition to operational efficiencies

Mr Don Malloy, Director Secure Packaging Systems, United States at Smart Healthcare USA 2004

Dr Peter Harrop, Chairman IDTechEx, United Kingdom at Smart Healthcare USA 2004

Dr Jay Lundell, Senior Researcher, Proactive Health Intel Corporation, United States at Smart Healthcare USA 2004